Red Palm Olein on Inflammation and Gut Health
RPO
1 other identifier
interventional
156
1 country
1
Brief Summary
A parallel intervention was conducted to test the effect of consuming diets enriched with red palm olein (RPOO), extra virgin coconut oil (EVCO) and extra virgin olive oil (EVOO; positive control) in centrally obese individuals over a 12-week period. Following the screening of the subjects' health status, including their biochemical and lipid profiles, the subjects completed a 12-week dietary intervention. Both fasting blood and urine samples were collected at baseline (day 0) and endpoint (week 12); measurements were taken in duplicates. All data collected were blinded to the investigators by an independent third party until the completion of the analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedFirst Submitted
Initial submission to the registry
December 20, 2022
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedMarch 30, 2023
March 1, 2023
5 months
December 20, 2022
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hs-C reactive protein (hsCRP)
Changes in the mean of plasma hs-CRP at the endpoint relative to the baseline. Plasma hsCRP will be measured using an immunoturbidimetric method, fibrinogen by Clauss method (Dade)
12 weeks
Secondary Outcomes (30)
Plasma lipid profile: Total cholesterol (mmol/L)
12 weeks
Plasma lipid profile: LDL cholesterol (mmol/L)
12 weeks
Plasma lipid profile: HDL cholesterol (mmol/L)
12 weeks
Plasma lipid profile: Triacylglycerol (mmol/L)
12 weeks
Plasma lipid profile: Apolipoprotein B-100 (g/L)
12 weeks
- +25 more secondary outcomes
Study Arms (3)
Red palm olein
EXPERIMENTALMeals enriched with Red palm olein
Extra virgin coconut oil
EXPERIMENTALMeals enriched with Extra virgin coconut oil
Extra virgin olive oil
EXPERIMENTALMeals enriched with Extra virgin olive oil
Interventions
Subjects consumed 3 isocaloric meals prepared with the 3 oils for a duration of 12 weeks. The test meals were given for 5-day a week and contained 27-30% energy fat, with 2/3 (20% energy fat) replaced by experimental fat.
Eligibility Criteria
You may qualify if:
- aged 25-45 years
- waist circumference ≥ 90 cm for men and ≥ 80 cm for women
You may not qualify if:
- BMI ≤ 18.5 kg/m2
- medical history of cardiovascular diseases
- positive for diabetes or dyslipidemia
- diagnosed with chronic illness
- plasma total cholesterol \> 6.5 mmol/L
- triacylglycerol \>4.5 mmol/L
- on antihypertensive or lipid-lowering medication
- lactating
- pregnant
- smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malaysia Palm Oil Boardlead
- Universiti Putra Malaysiacollaborator
Study Sites (1)
Malaysian Palm Oil Board
Kajang, Selangor, 43000, Malaysia
Related Publications (1)
Teng KT, Loganathan R, Chew BH, Khang TF. Diverse impacts of red palm olein, extra virgin coconut oil and extra virgin olive oil on cardiometabolic risk markers in individuals with central obesity: a randomised trial. Eur J Nutr. 2024 Jun;63(4):1225-1239. doi: 10.1007/s00394-024-03338-6. Epub 2024 Feb 19.
PMID: 38372798DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kim Tiu Teng, PhD
Malaysia Palm Oil Board
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- All data collected were blinded to the investigators by an independent third party until the completion of the analysis. The efficacy of the blinding procedure was assessed by evaluating the compliance of participants using the visual analogue scale to the experimental diets.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2022
First Posted
March 30, 2023
Study Start
January 1, 2019
Primary Completion
May 30, 2019
Study Completion
November 30, 2022
Last Updated
March 30, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share the individual participant data , provided requested specifically for scientific analysis purposes